Q2 2025 saw a 5% revenue decline year-over-year, but EBIT margin improved to 8.0%. Market uncertainty led to lower sales, though volumes normalized in June. A major asset sale is set to strengthen liquidity, and a new acquisition was completed.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.